| __timestamp | Supernus Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19586000 | 45967000 |
| Thursday, January 1, 2015 | 29135000 | 114737000 |
| Friday, January 1, 2016 | 42791000 | 183204000 |
| Sunday, January 1, 2017 | 49577000 | 231644000 |
| Monday, January 1, 2018 | 89209000 | 293998000 |
| Tuesday, January 1, 2019 | 69099000 | 357355000 |
| Wednesday, January 1, 2020 | 75961000 | 412084000 |
| Friday, January 1, 2021 | 90467000 | 497153000 |
| Saturday, January 1, 2022 | 74552000 | 705789000 |
| Sunday, January 1, 2023 | 91593000 | 648449000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is the key to staying ahead. Over the past decade, Ultragenyx Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc. have been at the forefront of this race. From 2014 to 2023, Ultragenyx consistently outpaced Supernus in research and development (R&D) spending, with an average annual investment nearly five times greater. In 2022, Ultragenyx's R&D expenses peaked at approximately 705 million, marking a staggering 1,435% increase from 2014. Meanwhile, Supernus showed a more modest growth, with a 368% increase over the same period. This significant disparity highlights Ultragenyx's aggressive pursuit of innovation, positioning it as a leader in the pharmaceutical industry. As these companies continue to invest in groundbreaking research, the future of medicine looks promising, driven by their relentless commitment to innovation.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and MannKind Corporation
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.